Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why

Benzinga_recent_news2025-12-25

Dynavax Technologies Corporation (NASDAQ:DVAX) shares are trending on Thursday. Check out the current price of DVAX stock here. Shares of the California-based biopharmaceutical company surged 38.19% ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2594821892?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/25/Business-Development--Financial-Plan-And.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-12-25 13:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2594821892","market":"hk","top_or_hot":-1,"title":"Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why","media":"Benzinga_recent_news","content":"<div>\n<p>Dynavax Technologies Corporation (NASDAQ:DVAX) shares are trending on Thursday.\nCheck out the current price of DVAX stock here.\nShares of the California-based biopharmaceutical company surged 38.19% ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49588738/dynavax-technologies-dvax-shares-are-trending-overnight-heres-why\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-25 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/12/49588738/dynavax-technologies-dvax-shares-are-trending-overnight-heres-why><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dynavax Technologies Corporation (NASDAQ:DVAX) shares are trending on Thursday.\nCheck out the current price of DVAX stock here.\nShares of the California-based biopharmaceutical company surged 38.19% ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49588738/dynavax-technologies-dvax-shares-are-trending-overnight-heres-why\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/12/49588738/dynavax-technologies-dvax-shares-are-trending-overnight-heres-why","article_id":"2594821892","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/25/Business-Development--Financial-Plan-And.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/12/49588738/dynavax-technologies-dvax-shares-are-trending-overnight-heres-why","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2594821892","pubTimestamp":1766640420,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","BK4150":"赌场与赌博","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU0251142724.SGD":"Fidelity America A-SGD","RSI":"Rush Street Interactive, Inc.","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","BK4588":"碎股","BK4550":"红杉资本持仓","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","BK4552":"Archegos爆仓风波概念","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0106831901.USD":"贝莱德世界金融基金A2","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","BK4504":"桥水持仓","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4516":"特朗普概念","BK4585":"ETF&股票定投概念","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","BK4139":"生物科技","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","DVAX":"德纳维制药","BK4127":"投资银行业与经纪业","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC"},"translate_title":"Dynavax Technologies(DVAX)股价隔夜上涨-原因如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVAX":1.5,"RSI":1},"content_text":"Dynavax Technologies Corporation (NASDAQ:DVAX) shares are trending on Thursday.\nCheck out the current price of DVAX stock here.\nShares of the California-based biopharmaceutical company surged 38.19% in the regular trading session on Wednesday, following Sanofi‘s announcement to acquire the vaccines company, before tapering slightly 0.065% to $15.37 in after-hours trading.\nSanofi, a French multinational pharmaceutical and healthcare company, will commence a cash tender offer to acquire all outstanding shares at $15.50 per share, representing approximately $2.2 billion in total equity value, according to Dynavax Technologies.\nThe offer price reflects a 39% premium over Dynavax’s Dec. 23 closing price and a 46% premium over its three-month volume-weighted average price as of Dec. 23, according to the company announcement.\nHEPLISAV-B, an adult hepatitis B vaccine currently available in the United States, is part of the acquisition. \nUnlike the usual three-dose schedule that takes six months, HEPLISAV-B is given in just two doses over one month.\nThomas Triomphe, Executive Vice President of vaccines at Sanofi, said, \"Dynavax enhances Sanofi’s adult immunization presence by adding differentiated vaccines that complement Sanofi’s expertise.\"\nThe Dynavax board unanimously approved the transaction. \nSee Also: Nike, Omeros Corporation, Micron Technology, Intel And Dynavax Technologies: Why These 5 Stocks Are On Investors' Radars Today\nDynavax Technologies noted that the Hart-Scott-Rodino Antitrust Improvements Act of 1976, a U.S. law requiring large mergers, acquisitions, and tender offers to notify the Federal Trade Commission and Department of Justice for antitrust review, along with the tender of at least a majority of outstanding shares, certain foreign regulatory filings and clearances, and other customary conditions, must all be satisfied before closing.\nSanofi intends fund the acquisition with available cash. \nDynavax said it was advised by Centerview Partners LLC and Goldman Sachs & Co. LLC (NYSE:GS).\nOn Wednesday, William Blair downgraded Dynavax Technologies from Outperform to Market Perform.\nThe stock has a relative strength index (RSI) of 89.44, a market capitalization of $1.81 billion, and an annual trading range of $9.20 to $15.49.\nDVAX has gained 18.04% over the past 12 months and 55.98% over the last six months, demonstrating a robust upward trend. This performance suggests the stock is well-positioned for continued growth.\nPrice Action: The stock of the commercial-stage company closed on Wednesday at $15.38, according to Benzinga Pro data.\nCurrently, the stock is trading at 98.3% of its 52-week range, indicating it’s near its highs. This positioning reinforces the bullish sentiment, but traders should remain cautious of potential pullbacks given the overbought RSI.\nBenzinga’s Edge Stock Rankings indicate that DVAX is experiencing long-term consolidation along with medium and short-term upward movement. Know how its momentum lines up with other well-known names.\nRead Next:\nPhoto Courtesy: Miha Creative on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2594821892","isCrawlerRequest":true}